For: | Mimeault M, Batra SK. Development of animal models underlining mechanistic connections between prostate inflammation and cancer. World J Clin Oncol 2013; 4(1): 4-13 [PMID: 23539141 DOI: 10.5306/wjco.v4.i1.4] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v4/i1/4.htm |
Number | Citing Articles |
1 |
Ian M. Thompson, April B. Cabang, Michael J. Wargovich. Future directions in the prevention of prostate cancer. Nature Reviews Clinical Oncology 2014; 11(1): 49 doi: 10.1038/nrclinonc.2013.211
|
2 |
Letícia Ferreira Alves, Raquel Frenedoso da Silva, Valéria Helena Alves Cagnon. Nintedanib effects on delaying cancer progression and decreasing COX-2 and IL-17 in the prostate anterior lobe in TRAMP mice. Tissue and Cell 2018; 50: 96 doi: 10.1016/j.tice.2017.12.008
|
3 |
Raúl Solís-Martínez, Georgina Hernández-Flores, Francisco Javier Ochoa-Carrillo, Pablo Ortiz-Lazareno, Alejandro. Bravo-Cuellar. Macrófagos asociados a tumores contribuyen a la progresión del cáncer de próstata. Gaceta Mexicana de Oncología 2015; 14(2): 97 doi: 10.1016/j.gamo.2015.03.001
|
4 |
Gianluigi Taverna, Elisa Pedretti, Giuseppe Di Caro, Elena Monica Borroni, Federica Marchesi, Fabio Grizzi. Inflammation and prostate cancer: friends or foe?. Inflammation Research 2015; 64(5): 275 doi: 10.1007/s00011-015-0812-2
|
5 |
Nadia Rucci, Patrizia Sanità, Simona Delle Monache, Edoardo Alesse, Adriano Angelucci. Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets. World Journal of Clinical Oncology 2014; 5(3): 335-347 doi: 10.5306/wjco.v5.i3.335
|
6 |
Gianluigi Taverna, Guido Giusti, Mauro Seveso, Rodolfo Hurle, Piergiuseppe Colombo, Sanja Stifter, Fabio Grizzi. Mast Cells as a Potential Prognostic Marker in Prostate Cancer. Disease Markers 2013; 35: 711 doi: 10.1155/2013/478303
|
7 |
Takeo Kosaka, Go Nagamatsu, Shigeru Saito, Mototsugu Oya, Toshio Suda, Katsuhisa Horimoto. Identification of drug candidate against prostate cancer from the aspect of somatic cell reprogramming. Cancer Science 2013; 104(8): 1017 doi: 10.1111/cas.12183
|
8 |
Xinyang Chen, Yu Li, Gang Li, Xuefeng Zhang, Gansheng Xie, Yuhua Huang, Huming Yin. Clinical significance of serum high sensitive C-reactive protein/albumin ratio in primary prostate biopsy. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1325524
|
9 |
João Lobo, Carmen Jerónimo, Rui Henrique. Targeting the Immune system and Epigenetic Landscape of Urological Tumors. International Journal of Molecular Sciences 2020; 21(3): 829 doi: 10.3390/ijms21030829
|
10 |
Jae-Wook Chung, Yun-Sok Ha, Sang Won Kim, Seung Chol Park, Taek Won Kang, Young Beom Jeong, Sung-Woo Park, Jinsung Park, Eun Sang Yoo, Tae Gyun Kwon, Sung Pil Seo, Ho Won Kang, Won Tae Kim, Yong-June Kim, Sang-Cheol Lee, Wun-Jae Kim, Seok Joong Yun, Tae-Hwan Kim. The prognostic value of the pretreatment serum albumin to globulin ratio for predicting adverse pathology in patients undergoing radical prostatectomy for prostate cancer. Investigative and Clinical Urology 2021; 62(5): 545 doi: 10.4111/icu.20210105
|
11 |
Mónica B. Gilardoni, María M. Remedi, Mabel Oviedo, Tristán Dellavedova, Juan P. Sarría, Laura Racca, Mariana Dominguez, Claudia G. Pellizas, Ana C. Donadio. Differential expression of Low density lipoprotein Receptor–related Protein 1 (LRP-1) and matrix metalloproteinase-9 (MMP-9) in prostate gland: From normal to malignant lesions. Pathology - Research and Practice 2017; 213(1): 66 doi: 10.1016/j.prp.2016.11.008
|
12 |
Hakmin Lee, Seong Jin Jeong, Sung Kyu Hong, Seok-Soo Byun, Sang Eun Lee, Jong Jin Oh. High preoperative neutrophil–lymphocyte ratio predicts biochemical recurrence in patients with localized prostate cancer after radical prostatectomy. World Journal of Urology 2016; 34(6): 821 doi: 10.1007/s00345-015-1701-6
|
13 |
Mauro Gacci, Elisabetta Baldi, Lara Tamburrino, Beatrice Detti, Lorenzo Livi, Cosimo De Nunzio, Andrea Tubaro, Stavros Gravas, Marco Carini, Sergio Serni. Quality of Life and Sexual Health in the Aging of PCa Survivors. International Journal of Endocrinology 2014; 2014: 1 doi: 10.1155/2014/470592
|
14 |
R. Arthur, R. Williams, H. Garmo, L. Holmberg, P. Stattin, H. Malmström, M. Lambe, N. Hammar, G. Walldius, D. Robinsson, I. Jungner, M. Van Hemelrijck. Serum inflammatory markers in relation to prostate cancer severity and death in the Swedish AMORIS study. International Journal of Cancer 2018; 142(11): 2254 doi: 10.1002/ijc.31256
|
15 |
Dipamoy Datta, Md. Aftabuddin, Dinesh Kumar Gupta, Sanghamitra Raha, Prosenjit Sen. Human Prostate Cancer Hallmarks Map. Scientific Reports 2016; 6(1) doi: 10.1038/srep30691
|
16 |
Sumeet Jain, Ajit Gopal Samal, Biswajit Das, Biswaranjan Pradhan, Nilanjan Sahu, Debasish Mohapatra, Prativa Kumari Behera, Partha Sarathi Satpathi, Akshaya K. Mohanty, Sanghamitra Satpathi, Shantibhusan Senapati. Escherichia coli, a common constituent of benign prostate hyperplasia‐associated microbiota induces inflammation and DNA damage in prostate epithelial cells. The Prostate 2020; 80(15): 1341 doi: 10.1002/pros.24063
|